BS_SDCNP7MW
EPN · EPN Tumor
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- EPN
- cancer_type_detailed
- —
- subtype
- EPN Tumor
- cancer_type
- EPN
- subtype
- EPN Tumor
- overall_survival_months
- 35.400000000000006
- os_event
- false
- age_years
- 12.575
- sex
- M
- race
- White
- e1_e2
- E2
- umap1_2d
- -6.562638032
- umap2_2d
- 1.160400712
- umap1_3d
- 0.453357017
- umap2_3d
- 4.028558139
- umap3_3d
- 0.698062829
- dataset
- EPN-CBTN
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- MYC_TARGETS_V1+0.300
- OXIDATIVE_PHOSPHORYLATION+0.260
- SPERMATOGENESIS+0.150
- DNA_REPAIR+0.140
- PROTEIN_SECRETION+0.130
- PEROXISOME+0.060
- ADIPOGENESIS+0.020
- BILE_ACID_METABOLISM+0.020
- PANCREAS_BETA_CELLS-0.010
- WNT_BETA_CATENIN_SIGNALING-0.010
Top 10 suppressed
- ANGIOGENESIS-0.500
- TNFA_SIGNALING_VIA_NFKB-0.470
- HYPOXIA-0.450
- INFLAMMATORY_RESPONSE-0.450
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.430
- IL2_STAT5_SIGNALING-0.400
- IL6_JAK_STAT3_SIGNALING-0.390
- ALLOGRAFT_REJECTION-0.380
- INTERFERON_GAMMA_RESPONSE-0.350
- INTERFERON_ALPHA_RESPONSE-0.310
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
2 twins match this tumor's tissue · 8 come from a different tissue of origin ← cross-tissue dominant
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | BS_SDCNP7MW | Ependymoma NOS | — | 0.971 |
| 2 | DRR168565 | — | — | 0.907 |
| 3 | SRR1441118 | GTEX | — | 0.900 |
| 4 | SRR1500537 | GTEX | — | 0.899 |
| 5 | R16 | — | — | 0.897 |
| 6 | SRR1394450 | GTEX | — | 0.894 |
| 7 | SRR1498702 | GTEX | — | 0.893 |
| 8 | SRR1405224 | GTEX | — | 0.893 |
| 9 | SRR1374246 | GTEX | — | 0.890 |
| 10 | MDT-AP-0395 | Med | Medulloblastoma | 0.890 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 8 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| MYC_TARGETS_V1 | 0.300 | Inavolisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.260 | Remibrutinib | — uncovered |
| SPERMATOGENESIS | 0.150 | Inavolisib | — uncovered |
| DNA_REPAIR | 0.140 | Idelalisib | — uncovered |
| PROTEIN_SECRETION | 0.130 | Remibrutinib | — uncovered |
| PEROXISOME | 0.060 | Idelalisib | — uncovered |
| ADIPOGENESIS | 0.020 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.020 | Inavolisib | — uncovered |